This information
collection is approved through December 1994. Upon resubmission,
FDA shall report: 1) The status of FDA's efforts to facilitate
electronic submissions; and 2) The approximate percentage of
reports for which no action is taken i.e., reported events that are
routine or are not significant.
Inventory as of this Action
Requested
Previously Approved
01/31/1995
01/31/1995
270,525
0
0
257,182
0
0
0
0
0
THIS NEW FORM WILL BE USED FOR
REPORTING ADVERSE EVENTS AND PRODUCT PROBLEMS WITH MEDICATIONS,
DEVICES, AND OTHER PRODUCTS (SUCH AS DIETAR SUPPLEMENTS) THAT ARE
REGULATED BY THE AGENCY.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.